# Effectiveness of High Flow Oxygen Therapy in Patients With Hematologic Malignancy Acute Hypoxemic Respiratory Failure

> **NCT03133520** · NA · COMPLETED · sponsor: **Kursat Gundogan** · enrollment: 102 (actual)

## Conditions studied

- Acute Hypoxemic Respiratory Failure
- Hematologic Malignancy

## Interventions

- **DEVICE:** High flow oxygen therapy

## Key facts

- **NCT ID:** NCT03133520
- **Lead sponsor:** Kursat Gundogan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-01
- **Primary completion:** 2018-09-14
- **Final completion:** 2018-09-14
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2020-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03133520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03133520, "Effectiveness of High Flow Oxygen Therapy in Patients With Hematologic Malignancy Acute Hypoxemic Respiratory Failure". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03133520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*